Wells Fargo & Company Lensar, Inc. Put Options Transaction History
Wells Fargo & Company
- $434 Billion
- Q3 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding LNSR
# of Institutions
40Shares Held
4.89MCall Options Held
700Put Options Held
31.3K-
North Run Capital, LP Wellesley, MA1.1MShares$8.07 Million7.54% of portfolio
-
Park West Asset Management LLC Larkspur, CA990KShares$7.29 Million0.37% of portfolio
-
Dimensional Fund Advisors LP Austin, TX649KShares$4.78 Million0.0% of portfolio
-
Brandes Investment Partners, LP La Jolla, CA443KShares$3.26 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA433KShares$3.19 Million0.0% of portfolio
About LENSAR, Inc.
- Ticker LNSR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 11,021,000
- Market Cap $81.1M
- Description
- LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in...